Mrowiec Fialek and Partners has advised Ipopema Securities S.A. on its entrance into investment and offering agreements with Biomed Lublin S.A.
Ipopema Securities is a provider of brokerage, financial, and transactional consulting services in public and private transactions, including mergers and acquisitions.
Biomed Lublin is a manufacturer of over 60 different medicinal products, medical devices, and laboratory reagents.
According to Mrowiec Fialek and Partners, Ipopema Securities, or an entity designated by the company, shall subscribe for up to 3,000,000 shares in Biomed Lublin in exchange for the proceeds of the sale of Biomed Lublim’s shares borrowed from its shareholders.
The Mrowiec Fialek and Partners team consisted of Partner Zbigniew Mrowiec, Counsel Sebastian Bogdan, and Senior Associate Joanna Kowalczyk.